Andrew J. Robertson,

Andrew practices in the areas of mergers and acquisitions, business and commercial law and corporate finance and securities. Andrew has experience in a variety of transactions, including share and asset acquisitions and divestitures, public and private offerings, corporate reorganizations, and various other corporate proceedings. Andrew works with public and private companies, including start-ups and entrepreneurs.

A significant portion of Andrew's practice involves advising private equity funds on fund formation and acquisitions and divestitures.

• Canadian Bar Association, Member
• Canadian Bar Association, Business Law Subsection, Member

• Canadian Mental Health Association: North and West Vancouver Branch - Director, Chair of the Governance Committee 

• Advised BDC Capital Inc., the investment arm of Business Development Bank of Canada, in connection with its minority equity investment in Delco Automation.
• Advised Dometic Group AB on Canadian matters in respect of its USD$875 million acquisition of SeaStar Solutions from affiliates of American Securities LLC.
• Advised Highland West Capital on its equity investment in the BID Group of Companies.
• Advised Ritchie Bros. Auctioneers Incorporated in connection with its acquisition of Kramer Auctions.
• Advised the shareholders of Thunderbird Marine Corp. on their sale of two marinas and associated real estate to an investment consortium led by Prospero International Realty.
• Advised Highland West Capital in its partnership arrangements with AllWest Insurance Services Ltd.
• Advised SemiosBio Technologies on multiple rounds of equity financing.
• Advised Ritchie Bros. Auctioneers Incorporated in its acquisition of the remaining 49% interest in Ritchie Bros. Financial Services Ltd. from a minority shareholder group.
• Advised several retail insurance brokerage businesses on acquisitions of brokerages across British Columbia.
• Advised multiple start-ups, primarily in the technology sector, on formation and organization.
• Advised numerous companies in relation to seed, Series A, and bridge financings.
• Advised OnCore BioPharma on Canadian matters in its merger with Tekmira Pharmaceuticals, valued at US $750 million.
• Acted for a gold mining company in the public offering of US$100,000,000 of common shares on the TSX and the NYSE MKT.